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Abstract: Toxoplasmosis is an antropozoonosis very frequent in population as a benign usually 
asymptomatic disease. The problems are raised by the congenital form of this disease that may 
occur if the women acquire the parasite during pregnancy leading to congenital toxoplasmosis. In 
order to prevent congenital toxoplasmosis many countries have screening programs design to 
diagnose the acute infection during fertile age of female population. Our prospective serologic 
study over a selected group of 510 pregnant women in Cluj county area showed a 39 % prevalence 
of toxoplasmic infection among women of fertile age, with a predominance of acute toxoplasmic 
infection during first trimester of pregnancy (66.66%), representing the predominant cause of 
abortion in our study group. Annual infection risk for female population aged 20-33 years old is K 
= 0.67% in our geographic area. A 4 % of cases had IgM persistence for more than 1-year period, 
and another 7% demonstrate positive IgM along with positive IgG raising the possibility of 
persistency to 11% of cases. We find out that half of women address laboratory by their own 
initiative and we calculate that medium age of pregnant women with toxoplasmic immunity 
(positive IgG) was 28 years old. 
Keywords: Antitoxoplasmic serology; Pregnant women; Toxoplasmosis annual infection risk; IgM 
persistency.  
Introduction 
Toxoplasmosis is an antropozoonosis very frequent in population [1] as a benign usually 
asymptomatic disease. The problems are raised by the congenital form of this disease [2] that may 
occur if the women acquire the parasite during pregnancy leading to congenital toxoplasmosis. In 
order to prevent congenital toxoplasmosis many countries have screening programs design to 
diagnose the acute infection during fertile age of female population [3]. 
There is no official national program for the follow-up of pregnant women in our country. 
Studies regarding prevalence and annual incidence of toxoplasmic infection among women of 
fertile age are made by different independent group of researchers [4-6]. Powerful lobby among 
women of fertile age for performing this analysis is especially carried out by laboratory doctors 
specialized in parasitology [7], but with few support from family doctors and gynecologists 
regarding interpretation of the results according with actual criteria and their attitude towards the 
female patient. IgM persistence (residual IgM) [8,9] it’s a phenomenon hardly recognized and rarely 
correct interpreted by clinicians leading sometimes to unnecessary stress for the female patient. 
The objective of our study was medical and statistic interpretation of the epidemiologic, clinic 
and serologic data obtained by clinical and laboratory investigation in order to estimate: 
  The prevalence of T. Gondii infection in women of fertile age from our geographic area,  
  The annual infection risk,  COSTACHE Carmen A., ŢIGAN Ştefan I., COLOSI Ioana and COROIU Zoe 
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  The percentage of persistent forms of toxoplasmic infection for the above-mentioned category 
of population.  
  Appreciation of the association degree between acute toxoplasmic infection and pregnancy 
loss. 
Material and Method 
We performed a prospective study on a selected group of 510 pregnant women between 2005-
2007 to whom we determine the serologic toxoplasmic profile (IgG, IgM and IgA) and registered 
epidemiological data (age, pregnancy age). Selection criteria were: living in Cluj county or neighbor 
counties (Alba, Mureş, Bihor, and Bistriţa), age between 16 - 42 years. 
Laboratory diagnosis for the serologic profile of the studied cases was a manual Enzyme Linked 
Immunosorbent Assay (ELISA) performed with Bio-RAD, Platelia kits, and for IgG positive sera 
accompanied by IgM and/or IgA the avidity test was performed. All sera were analyzed in duplicate 
and the results were checked by the same method performed with a kit from another producer.  
Statistic data analysis was made with the following programs: EPIINFO 6, EPIINFO 2000, 
SPSS10, standard level of statistic significance was considered α = 0.05, and the tests used were: χ2 
(Hi-square) test, Mann –Whitney (U) test, Student Test (T). For frequencies and averages, 
confidence intervals were calculated. Annual infection risk was calculated based on published 
formula of Papoz & all. [10]. 
Results 
The structure of this group of pregnant women show that the majority of pregnancies were 
present in the 26-30 years old group - 242 (Figure 1) and the repartition of pregnant women 
according with gestational age is presented in Figure 2. 
Toxoplasmic infection seroprevalence, demonstrated by the presence of antitoxoplasmic IgG, 
was ascertained in 198 (39%), of 510 tested pregnant women, CI = [34.57% – 43.20%], the rest of 
312 pregnant women (61%) being seronegative, CI = [56.79%-65.42%] (Figure 3). Detailed 
serologic profile of positive pregnant women is showed in Figure 4 and 5. 
 
 
Figure 1. Pregnant women distribution according with age 
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Figure 2. Pregnant women distribution according with pregnancy age 
 
 
Figure 3. Seroprevalence of toxoplasmic infection in pregnant women group 
 
 
Figure 4. Serologic profile of studied cases. Emphasize of IgM persistence 
 
Repartition of acute toxoplasmosis cases during pregnancy according with the time of the 
pregnancy was 66.66%, CI=[40.99-86.65] trimester I, 27.77%, CI=[9.69-53.48%] in trimester II and 
only 5.5%, CI=[0.1%-27.29%] in trimester III (Figure 6); acute toxoplasmosis effect on pregnancy 
evolution is demonstrated in Figure 7. 
In order to calculate the annual risk of infection with T. gondii in pregnant women with the age 
in 20-26 years interval and 27-33 years interval the following date are used (Table 1). 
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Figure 5. Detailed serologic profile of pregnant women 
 
 
 
Figure 6. Repartition of toxoplasmic infection during pregnancy according with pregnancy 
trimester 
 
 
 
Figure 7. Effect of toxoplasmic infection acquired during pregnancy on the evolution of pregnancy 
Table 1. Annual infection risk (K) for 20-33 years of age interval 
Age group (years)  Pregnant women number IgG+ % IgG+  IgG- % IgG 
20-26 196  78  39.79592 118  P0=  60.20408 
27-33 282  121  42.9078  161  P1=  57.0922 
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Annual infection risk is: K= 0.6697%. 
Analyzing the source which determine pregnant women to address laboratory for testing we 
obtained the following results: 56 % address from their own initiative (42 % of them having a 
normal pregnancy in evolution and 14 % because they had a spontaneous abortion in recent history 
or a child with congenital abnormalities); 27 % were send to the laboratory by the general 
practitioner and 17% were send by the gynecologist (Figure 8). 
 
 
Figure 8. Addressability according to source 
Discussion 
The percentage of positive serology (IgG positive 39 %) in pregnant women group follows the 
line of IgG positivity in females of fertile age between 35-40% found by other studies across 
Europe [11] and in our area [12]. 
In the cases of 167 pregnant women CI = [78.51% - 89.1%] with positive, constant and low 
level of IgG and negative IgM and IgA, categorization as immune to toxoplasmosis was simple. 
Clinic interpretation became more complicated in those cases where the presence of IgG was 
accompanied by the presence of  IgM and/or IgA, 31 of them, CI = [10.89 % –21.48 %], belonging 
to these category. In order to establish the diagnostic in these cases we had to consider other 
parameters as follows: for 9 cases (29%), positive IgM and IgA and high values for IgG (>250 
UI/ml), we performed affinity/avidity test that allow us to frame this cases within category of 
toxoplasmosis during pregnancy, because the avidity was low. It has to be considered that a low 
affinity may not give a correct interpretation as a single parameter because it may persist in some 
cases for at least 6 moths, but when summed to other results (as in our case) it can make the 
difference between chronic infection and recently infection [13] and it may ensure a good evolution 
of pregnancy with no risk for the transmission of the infection to the child [14]. 
Conclusions 
1.  Antitoxoplasmic seropositivity in pregnant women from our geographic area is 39%, annual 
infection risk for female population with age between 20-33 years old is K = 0.67%, with an 
age increasing evolution. 
2.  Medium age of pregnant women with toxoplasmic immunity ( positive IgG) was 28 years old 
3.  Addressability of pregnant women for testing is reaching a maximum during first trimester of 
pregnancy and is mainly due to self initiative, followed by recommendation from family doctor 
and gynecologist. The interest for testing decrease with the evolution of pregnancy.  
4.  Diagnosis of acute toxoplasmic infection during pregnancy was established in 3% of all tested 
women, majority of them during first trimester of pregnancy, being the major cause of 
abortion in our study group.  
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5.  Almost half of pregnant women with positive IgG need additional tests for confirmation of 
the clinical status due to a complex serology (presence of IgM and sometimes IgA) in a 
punctual determination (disadvantages of non-dynamic follow-up). 
6.  Antitoxoplasmic IgM persistence phenomenon (residual IgM) is frequent (CI=2-34 %) in 
female population with positive serology..  
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